返回ChemicalBook首页>CAS数据库列表>376640-41-4

376640-41-4

中文名称 BVT 2733
英文名称 BVT 2733
CAS 376640-41-4
分子式 C17H21ClN4O3S2
分子量 428.96
MOL 文件 376640-41-4.mol
更新日期 2024/07/01 17:51:36
376640-41-4 结构式 376640-41-4 结构式

基本信息

中文别名
化合物BVT 2733
3-氯-2-甲基-N-(4-(2-(4-甲基哌嗪-1-基)-2-氧代乙基)噻唑-2-基)苯磺酰胺
英文别名
BVT2733, >98%
BVT 2733(BVT.2733)
BVT.2733 >=98% (HPLC)
3-chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide
BENZENESULFONAMIDE, 3-CHLORO-2-METHYL-N-[4-[2-(4-METHYL-1-PIPERAZINYL)-2-OXOETHYL]-2-THIAZOLYL]-
3-CHLORO-2-METHYL-N-[4-[2-(4-METHYLPIPERAZIN-1-YL)-2-OXOETHYL]-1,3-THIAZOL-2-YL]BENZENESULFONAMIDE
所属类别
生物化工:激动剂抑制剂

物理化学性质

沸点636.9±65.0 °C(Predicted)
密度1.427±0.06 g/cm3(Predicted)
储存条件Sealed in dry,2-8°C
溶解度≥42.9 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
酸度系数(pKa)6.36±0.10(Predicted)
形态固体
颜色Off-white to pink

安全数据

危险性符号(GHS)
GHS07
警示词警告
危险性描述H302
防范说明P301+P312+P330
海关编码2935909099
BVT 2733价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/08/19S0209BVT 2733
BVT 2733
376640-41-45mg657.46元
2024/08/19S0209BVT 2733
BVT 2733
376640-41-425mg2383.47元

常见问题列表

生物活性
BVT 2733 是一种新型的、小分子、非甾体类、异构体选择性的 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) 的抑制剂。
靶点
TargetValue
11β-HSD1
()
体外研究

BVT 2733 (100 μM; 24 hours) co-treatment with PA (100 µM) reduces MCP-1 expression in fully differentiation adipocytes.BVT 2733 (50-100 μM; 24 hours) reduces the inflammation protein levels (MCP-1, IL-6) in medium in J774.1 macrophages by Elisa.

RT-PCR

Cell Line: Differentiation adipocytes
Concentration: 100 μM
Incubation Time: 24 hours
Result: Down-regulated MCP-1 mRNA level.
体内研究

BVT-2733 (oral administration; 100 mg/kg; twice daily; 2 weeks) attenuates the arthritis severity and anti-CII level and decreases the levels of serum TNF-α, IL-1β, IL-6 and IL-17 in CIA mice.BVT 2733 (oral administration; 100 mg/kg; dosed (09.00 and 17.00 h); last 4 weeks) exhibits decreased body weight and enhanced glucose tolerance and insulin sensitivity when it compares to control mice. It also down-regulated the expression of inflammation-related genes including monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor alpha (TNF-α) and the number of infiltrated macrophages within the adipose tissue in vivo.

Animal Model: Collagen-induced arthritis (CIA) mice
Dosage: 100 mg/kg
Administration: Oral administration; twice daily; 2 weeks
Result: Reduced synovial inflammation and joint destruction.
Animal Model: C57BL/6J mice
Dosage: 100 mg/kg
Administration: Oral administration; dosed (09.00 and 17.00 h); last 4 weeks
Result: Improved metabolic homeostasis and suppressed the inflammation of adipose tissue in diet-induced obese mice.
"376640-41-4" 相关产品信息